Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
27 Jan 2015 Annals of Oncology Press Release: Lung Cancer Predicted to Overtake Breast Cancer as Leading Cause of Cancer Death Among European Women in 2015 Lung and other thoracic tumours
26 Jan 2015 ESMO Press Release: ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe
26 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jan 2015 Successful Implementation of SPECTAcolor, the First Pan-European and EORTC Screening Platform, Proves that a Logistically Complex Infrastructure to Run Next Generation Trials in a Multinational Setting is Feasible Personalised medicine - Translational research - Gastrointestinal cancers
20 Jan 2015 First-Line FOLFOXIRI/Bevacizumab Improves Long-Term Outcomes in Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
19 Jan 2015 Second-Line Treatment with FOLFIRI/Ramucirumab Delays Disease Progression and Extends Overall Survival in Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jan 2015 Next Generation Sequencing Reveals Genetic Landscape of Breast Phyllodes Tumours Breast cancer - Translational research
14 Jan 2015 Many Cancer Survivors Have Unmet Physical and Mental Needs Palliative and supportive care
13 Jan 2015 Anticancer Medicines Recommended for Approval by EMA in 2014 Anticancer agents & Biologic therapy
12 Jan 2015 Screening for HPV Infection Alone More Accurate Than Pap Test in the Detection of Cervical Cancer, Especially in Younger Women Epidemiology/Etiology/Cancer Prevention - Gynaecologic malignancies
09 Jan 2015 Stereotactic Body Radiation Therapy Plus Erlotinib for Stage IV Limited, but Progressive, Metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
08 Jan 2015 Statistical Modeling Links Cancer Risk With Number of Stem Cell Divisions Translational research
07 Jan 2015 TRK Cancer-Causing Mutation Discovered in 1982 Finally Target of Clinical Trials Translational research - Anticancer agents & Biologic therapy
05 Jan 2015 FDA Approves Nivolumab for Patients with Advanced, Refractory Melanoma Melanoma - Immuno-oncology
24 Dec 2014 FDA Approves Olaparib for BRCA-Mutated Patients with Heavily Pretreated Advanced Ovarian Cancer Personalised medicine - Gynaecologic malignancies - Anticancer agents & Biologic therapy